Screening for metabolic risk factors in women treated for schizophrenia
Abstract
Metabolic syndrome is a risk factor
for cardiovascular disease (CVD) and premature death, especially
in people with severe mental illness, such as schizophrenia.
Metabolic risk factors are partially attributable to unhealthy
lifestyle, including poor diet and lack of regular physical activity,
as well as side effects of antipsychotic medications [1−3]. Women
diagnosed with schizophrenia and treated with antipsychotic medications constitute a specific subgroup of the population with
higher risk for developing metabolic syndrome, and therefore they
should be routinely screened and treated for metabolic risk factors.
In this pilot study, we investigated the metabolic risk factors
among hospitalized women treated for schizophrenia
Source:
European Neuropsychopharmacology, 2013, 23, S467-S468Publisher:
- Elsevier Science BV, Amsterdam
Institution/Community
Psihologija / PsychologyTY - JOUR AU - Batinić, Borjanka AU - Đerić-Jeremić, M. AU - Duisin, Dragana AU - Opačić, Goran PY - 2013 UR - http://reff.f.bg.ac.rs/handle/123456789/1705 AB - Metabolic syndrome is a risk factor for cardiovascular disease (CVD) and premature death, especially in people with severe mental illness, such as schizophrenia. Metabolic risk factors are partially attributable to unhealthy lifestyle, including poor diet and lack of regular physical activity, as well as side effects of antipsychotic medications [1−3]. Women diagnosed with schizophrenia and treated with antipsychotic medications constitute a specific subgroup of the population with higher risk for developing metabolic syndrome, and therefore they should be routinely screened and treated for metabolic risk factors. In this pilot study, we investigated the metabolic risk factors among hospitalized women treated for schizophrenia PB - Elsevier Science BV, Amsterdam T2 - European Neuropsychopharmacology T1 - Screening for metabolic risk factors in women treated for schizophrenia EP - S468 SP - S467 VL - 23 DO - 10.1016/S0924-977X(13)70740-5 ER -
@article{ author = "Batinić, Borjanka and Đerić-Jeremić, M. and Duisin, Dragana and Opačić, Goran", year = "2013", abstract = "Metabolic syndrome is a risk factor for cardiovascular disease (CVD) and premature death, especially in people with severe mental illness, such as schizophrenia. Metabolic risk factors are partially attributable to unhealthy lifestyle, including poor diet and lack of regular physical activity, as well as side effects of antipsychotic medications [1−3]. Women diagnosed with schizophrenia and treated with antipsychotic medications constitute a specific subgroup of the population with higher risk for developing metabolic syndrome, and therefore they should be routinely screened and treated for metabolic risk factors. In this pilot study, we investigated the metabolic risk factors among hospitalized women treated for schizophrenia", publisher = "Elsevier Science BV, Amsterdam", journal = "European Neuropsychopharmacology", title = "Screening for metabolic risk factors in women treated for schizophrenia", pages = "S468-S467", volume = "23", doi = "10.1016/S0924-977X(13)70740-5" }
Batinić, B., Đerić-Jeremić, M., Duisin, D.,& Opačić, G.. (2013). Screening for metabolic risk factors in women treated for schizophrenia. in European Neuropsychopharmacology Elsevier Science BV, Amsterdam., 23, S467-S468. https://doi.org/10.1016/S0924-977X(13)70740-5
Batinić B, Đerić-Jeremić M, Duisin D, Opačić G. Screening for metabolic risk factors in women treated for schizophrenia. in European Neuropsychopharmacology. 2013;23:S467-S468. doi:10.1016/S0924-977X(13)70740-5 .
Batinić, Borjanka, Đerić-Jeremić, M., Duisin, Dragana, Opačić, Goran, "Screening for metabolic risk factors in women treated for schizophrenia" in European Neuropsychopharmacology, 23 (2013):S467-S468, https://doi.org/10.1016/S0924-977X(13)70740-5 . .